Scientific EXPERT Act of 2024
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
The Scientific EXPERT Act of 2024 amends the Federal Food, Drug, and Cosmetic Act to establish a process for externally led, science-focused drug development meetings focused on rare diseases and conditions. The bill requires the Reagan-Udall Foundation to convene at least four such meetings annually, with a multistakeholder steering committee guiding topic selection and participation. The FDA must participate in these meetings and publicly report how input from them is incorporated into drug approval decisions, with $1 million annually authorized for fiscal years 2025–2029.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.